Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q2 2023 Earnings Call Transcript

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q2 2023 Earnings Call Transcript August 2, 2023

Karyopharm Therapeutics Inc. misses on earnings expectations. Reported EPS is $-0.62 EPS, expectations were $0.34.

Operator: Good morning. My name is Jason and I will be your conference operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics Second Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please be advised that this call is being...